Prudence Lifecare Pvt. Ltd.
Febuxostat
Manufactured and supplied from our WHO-GMP, GLP and ISO 9001:2015 certified facility in Ankleshwar, Gujarat, India. Febuxostat is a selective, non-purine xanthine oxidase (XO) inhibitor used in the chronic management of hyperuricemia in gout.
- CAS Number
- 144060-53-7
- PubChem CID
- 134018
- Molecular Weight
- 316.37 g/mol
- Pharmacopoeia
- IHS
What is Febuxostat?
Febuxostat is a selective, non-purine xanthine oxidase (XO) inhibitor used in the chronic management of hyperuricemia in patients with gout. As a thiazole carboxylic acid, it differs structurally from purine-based XO inhibitors. Prudence Lifecare's Febuxostat is manufactured to IHS pharmacopoeial standard, and Prudence's own intermediates range includes two of the compound's genuine synthesis building blocks — both isobutoxyphenyl-thiazole ester intermediates — manufactured in-house.
Applications & industries served
- Hyperuricemia formulations
- Chronic gout management
- Xanthine oxidase inhibitor products
- Generic & contract (CDMO) manufacturing
- Pharmaceutical research & QC reference
Chemical & technical data
Full verified identifiers for Febuxostat, cross-checked against PubChem and supplier reference data.
| Product Name | Febuxostat |
|---|---|
| CAS Number | 144060-53-7 |
| PubChem CID | 134018 |
| Molecular Formula | C16H16N2O3S |
| Molecular Weight | 316.37 g/mol |
| Exact Mass | 316.0882 |
| IUPAC Name | 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
| InChIKey | BQSJTQLCZDPROO-UHFFFAOYSA-N |
| Pharmacopoeia Standard | IHS |
| Classification | Non-purine selective xanthine oxidase inhibitor |
Chemical identity data sourced and cross-verified via PubChem (CID 134018). Specification, purity grade, packaging and Certificate of Analysis details available on request.
Manufacturing & supply
Prudence Lifecare Pvt. Ltd., Unit-II of Prudence Pharma Chem (established 2003), is a WHO, GMP, GLP and ISO 9001:2015 certified Active Pharmaceutical Ingredient manufacturer based in GIDC Ankleshwar, Gujarat, India. Febuxostat is manufactured under the same quality systems that govern our full API and intermediates portfolio, supplying formulation companies and generic manufacturers across India and exporting to Asia, Europe, Africa and the Middle East.
Quality, certifications & documentation
- WHO-GMP, GLP, ISO 9001:2015 and ISO 14001 certified facility
- Manufactured to IHS pharmacopoeial standard
- Certificate of Analysis (CoA) available on request
- DMF/CEP documentation status — contact our export sales team to confirm current filing status for this product
Why choose Prudence Lifecare
- WHO, GMP, GLP and ISO-certified facility in Ankleshwar, Gujarat, India
- IHS pharmacopoeia-grade Febuxostat
- In-house manufacture of both thiazole-ester synthesis intermediates
- Export experience across Asia, Europe, Africa and the Middle East
- Custom synthesis and contract manufacturing (CDMO) capability for related molecules
Frequently asked questions
What is Febuxostat?
Febuxostat is a selective, non-purine xanthine oxidase (XO) inhibitor used in the chronic management of hyperuricemia in patients with gout.
What is the CAS number of Febuxostat?
144060-53-7.
What is the molecular formula of Febuxostat?
C16H16N2O3S.
What is the molecular weight of Febuxostat?
316.37 g/mol.
Which pharmacopoeia standard does Prudence Lifecare's Febuxostat meet?
IHS.
Who manufactures Febuxostat in India?
Prudence Lifecare Pvt. Ltd. manufactures Febuxostat at its WHO-GMP certified facility in Ankleshwar, Gujarat, India.
Is Febuxostat available from Gujarat or Ankleshwar?
Yes — Prudence Lifecare's manufacturing facility is located in GIDC Ankleshwar, Gujarat, India.
Does Prudence Lifecare export Febuxostat internationally?
Yes, Prudence Lifecare exports its API and intermediates portfolio, including Febuxostat, to Asia, Europe, Africa and the Middle East.
What is the PubChem CID of Febuxostat?
134018.
What are the synonyms of Febuxostat?
TMX-67, TEI-6720. Marketed by the originator under the brands Uloric and Adenuric.
What intermediates does Prudence Lifecare manufacture for Febuxostat?
Prudence Lifecare manufactures Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate (CAS 161798-03-4) and Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate (CAS 160844-75-7) — the latter is the direct ethyl-ester precursor of Febuxostat.
What is the general mechanism of action of Febuxostat?
Febuxostat selectively inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine and xanthine into uric acid, lowering serum uric acid levels.
Is Febuxostat manufactured under GMP conditions at Prudence Lifecare?
Yes — Prudence Lifecare's facility is WHO, GMP, GLP and ISO 9001:2015 certified.
Can Prudence Lifecare provide a Certificate of Analysis (CoA) for Febuxostat?
Yes, a Certificate of Analysis is available on request — contact our export sales team.
Does Prudence Lifecare offer DMF/CEP documentation for Febuxostat?
Contact our export sales team to confirm current DMF/CEP filing status for this product.
How can I request a quote or technical documentation for Febuxostat?
Use the "Request a quote" button on this page or visit our Contacts page.
What industries purchase Febuxostat from Prudence Lifecare?
Formulation companies, generic pharmaceutical manufacturers, and contract manufacturers producing antigout and hyperuricemia-management tablet products.
Need pricing, a Certificate of Analysis, or DMF/CEP documentation for Febuxostat?
Contact our export sales team